The U.S. Court of Appeals for the Federal Circuit (CAFC) reversed a district court’s decision in Snaprays (dba SnapPower), v. Light Defense Group (LDG) on May 2, finding that Lighting Defense Group ...
A client’s recent experience applying for a European patent led to the development of a possible optimization strategy to address patent costs for clients. This client had made an initial U.S. filing ...
The U.S. Patent and Trademark Office (USPTO) recently released new guidance for practitioners using artificial intelligence ...
Expansion to FTC’s Orange Book Campaign Leads to Calls for More Clarity from Pharmaceutical Industry
On April 30, the Federal Trade Commission (FTC) announced that it was expanding its campaign against allegedly improper ...
The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision today vacating and remanding with ...
The U.S. Senate Judiciary Committee’s Subcommittee on Intellectual Property met today to hear from six witnesses about a ...
“The stated goal of facilitating commercialization in particular may seem contradictory to some, considering the ...
“[T]he Federal Circuit noted that questions about a party’s ability to license patent rights do not provide a reasonable ...
“Using section 1498 would not significantly reduce drug costs because, as courts have repeatedly recognized, the law requires the government to provide ‘reasonable and entire compensation’ for any ...
Epstein Becker & Green is seeking an intellectual property associate to join its Health Care & Life Sciences practice in our ...
GlaxoSmithKline filed a four-count civil action for patent infringement in the United States District Court for the District ...
Standard Essential Patent (SEP) litigation is global and SEP owners often follow a strategy to enforce their SEPs in multiple ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results